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Abstract

Neuropeptide Y(NPY), discovered in 1982, is one of the most abimdant

neuropeptides found in the mammalian brain. It is also stored and secreted as a
hormone from chromaffm cells in the body. It has been shown to regulate cardiac

blood pressure, intracellular calcium concentrations in tissue culture, and pineal gland
production and secretion of the hormonemelatonin, all which have been shown to be
affected by exposure to magnetic fields(MF). In this thesis, I examined the effects of
MF exposure on the chemically induced production of NPY mRNA in the rat

pheochromocytoma, PC-12 cell line. NPY mRNA production is regulated in these

cells by at least three differerii signal transduction mechanisms,the
phosphoinositide/protein kinase C(PRC)dependent, the cAMP dependent, and a
tyrosine kinase dependent mechanism with a synergism occurring upon simultaneous
stimulation of both the phosphoinositide/PKC and the cAMP dependent pathways.
There is a significant decline in the synergistic production of NPY mRNA in

PC-12 Cells stimulated with forskolin(20uM)and TPA(50nM)upon magnetic field

exposure. This decline was seen at 8 and 24 hours of chemical plus MF exposure. To
determine whether or not a specific signal transduCtiOn pathway wks affected by MF

exposure, PC-12 cells were exposed to TPA (12-0-tetradecanoylphorbol-13-acetate)

(50nM), or forskolin(20uM)for 8 hows with and without MF exposure. No changes
in NPY mRNA were seen between magnetic field and sham exposed unstimulated

cells, or in those cells exposed to forskolin(20uM). In three offow experiments,

those cells exposed to TPA(50nM)and magnetic field showed an average 27%,36%,
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and 24%(p <0.05), decline in NPY mRNA It has been shown that transcript stability
of llie GAP-43 gene in PC-12cells can be affected

ofPEG. To

determine if the MF induced decline in NPY mRNA waS at the posttranscriptional

level, cells were incubated Fhh TPA(50nM)for $ houK at which time,DRB (5,6
Dichloro-l-BnD-Ribo-Exu-anQsyl-Benzimidazole)(65uM),^inhibitor of transcription
was added. RNA was extracted at various time points thereafter. The TPATinduced

half^life wM approximately 12 hours in both magnetic field and sham exposed
cultures. Theae results indicate exposure to a 1 gauss, 60 Hz magnetic field affects a
an

in PG-12 cells and this effect does not appear to be at the posttranscriptional level.
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INTRODUCTION

Low-frequency elecfromagnetie field(EMF)interactions with biological

systems have been recorded for the last twenty years. Only in the last deeade or so,
has exposure to these fields been implicated with higher incidences of cancer. Today,
there is an overwhelming demand to clarify the issue of electromagnetic fields possibly
interacting with biological systems to promote cancer.

Epidemiological studies have shown that a correlation exists between exposure
to EMF's and increased incidences of cancer, e.g., childhood leukemia, brain, and
breast cancers, and an increased incidence of miscarriage (Feychting M. et. al, 1992;
Savitz D. ct. al, 1990; Myers A. et. al, 1990; Goldhabler M. et. al, 1988;
Wertheimer N. et. al, 1979, 1989; Delgado J. et. al, 1982). A current theory is that

these EMF's are not promoting cancer by themselves, but are possibly enhancing the
effects of exposure to low doses of known carcinogens, i. e. co-promotion(Adey, W.,

1990). Recently, a cellular model offocus formation has been used to demonstrate an
increase in focus formation of cells grown in the presence of a known tumor promotor,

TPA (phorbol 12-myristate 13-acetate), and a 60 Hz, 1 gauss magnetic field (Cain C.

et. al, 1993). The mechanism responsible for this effeet is not yet understood,

although it has also been shown that expression of early activation genes can be
affected in a specific manner by EMF exposure(Goodman R. et. al, 1983, 1986,
1989; Phillips J. et. al, 1992). It is possible that there exists similar mechanism(s)

suseeptible to magnetic field exposure within both of those findings. For instance,
TPA has been shown to direetly bind and activate protein kinase C which will in turn
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phosphorylate transcription factors changing the rate of transeription of certain genes.
A molecular mechanism by which EMF's can interact with biological systems
needs to be identified if this research is to have any real credibility. There is good
evidence that the meehanism is associated with the eell membrane, perhaps at the level

of signal transduction(Adey W.R., 1986, 1988). Evidence exists implying second

messengers such as cAMP,and Ca2+ as the site of EMF-cellular interaction(Bawin S.
and Adey W., 1976; Cain C. et. al, 1987; Walleczek J. et. al, 1990; Liburdy R. et.
al, 1993). The question of whether the alteration of this molecular mechanism leads
to plausible susceptibility to various forms of cancer needs to be addressed. The focus
formation model reported by Cain et. al, 1993, answers the question of whether
mechanism alterations caused by EMF exposure can lead to enhanced focus formation,
while not yet identifying a meehanism.

Another possible answer to the question of whether exposure to EMF's changes

the susceptibility to cancer is demonstrated by the finding of decreased pineal
production of the hormone melatonin in animals exposed to EMF's (Reiter R. et. al,
1992; Wilson B. et. al 1981, 1986, 1990; Welker H. et. al, 1983). There is some
evidence that melatonin could be involved in the body's natural defense against

certain cancers. Blood levels of circulating melatonin decline in patients with various
forms of cancer. This observed decline in melatonin was attributed specifieally to a

decrease of synthesis and release from the brain (Bartsch C. et. al, 1985,1989). As of

yet, there is no identified molecular mechanism being affected by EMF exposure that
would lead to deelined production of melatonin. Natural regulation of melatonin

secretion is due partly to pineal gland adrenergic receptor stimulation by

norepinephrine, which is released dtiring dark periods of the circadian cycle(Moore R.
etral., 1968).

Another known regulator of pineal production and secretion of rhelatonin is the

neuropeptide, Neuropeptide Y(NPY)(Glcese J.^r aL, 1991; Vacas M. et. al, 1987;
Reuss S. et. a/., 1989). Neuropeptide Y(NPY)is a 36-aininO acid peptide originally

isolated from porcine brain in 1982(Tatemoto K. et. a/.,1982). It is among the most

abundant neuropeptides found in the brain (de Quidt M. et. ah, 1986), and appears to

be an important regulator in the mammalian nervous system. There is evidence this
neuropeptide plays a significant role in the regulation of cardiac artery blood pressure
(Lundberg J. et. ah, 1982), hormonal release from the brain (Kerkerian L. et. ah,
1985), and feeding behavior (Stanley B. and Leibowitz S., 1985; Stanley B. et. ah,
1993; Stanley B. and Thomas W.^ 1993). It is found co-localized with other
catecholamines and appears to be involved in regulating their secretion(Guy J. and
Pelletier G., 1988). NPY is also stored and secreted as a hormone from adrenal
chromaffin cells (Allen J. et. ah, 1983), and is widely distributed throughout the body.

The gene expression of NPY is an ideal system to use for the study of

biological effects of stimuli on cell membrane signal transduction because NPY gene

expression: appears to be dependent on at least three signal transduction mechanisms;
the phosphoinositide/protein kinase C,the cAMP,and a tyrosine kinase dependent
mechanism (Higuchi H. et. a/., 1988; Sahol S. at. a/., 1990). This regulation of NPY

gene expression has been demonstrated in fetal aggregating brain cells(Magni P. et.

al, 1992) as well as in tjie rat PC-12 pheochromGcytoma cell line (Higuchi H. et. al,
1988; Sabol S. et. a/., 1990). A novel aspect of NPY gene regulation in PC-12 cells is
that activation of both cAMP and protein kinase C dependent signal transduction

mechanisms concurrently leads to a synergism in the production of NPY niRNA where
the levels obtained are far greater than if the mechanisms were additive (Higuchi H. et.
al, 1988; Sabol S. ef a/., 1990). The mechanism(s) for this phenomena are unknown

although similar effects have been seen with other genes in other cell lines(Comb M.
et. al, 1986; Anderson B. et. al, 1988),

I chose to examine whether exposure to EMF's can alter the chemically induced

production of NPY in the rat pheochromocytoma cell line PC-12 using NPY prepro
mRNA as a marker. This cellline has been shown to be responsive to EMF exposure.

The PC-12 cell line has been extensively used to study the process of neuronal

differentiation. Upon exposure to Nerve Growth Factor, these cells begin to form

neurite processes. This neurite forming process appears to be altered in the presence
of a magnetic field(Blackman C. er. al., 1993a, 1993b). Also, these cells are known

to produce and secrete catecholamines. The secretion of the catecholeamines has also
been shown to be affected upon exposure to EMF's(Dixey R. and Rein G., 1982).

In this study, PC-12 cells were exposed to a 60 Hz, 1 gauss sinusoidal
magnetic field with the measurement of NPY mRNA expression used as an endpoint.
The hypothesis was that exposure to the magnetic field would alter one or more ofthe
before mentioned signal transduction pathways leading to an alteration in the

production of NPY mRNA in PC-12 cells. It was demonstrated that exposure to this

by the combined actions offorskolin and TPA . It was also demonstrated that NPY
mRNA is induced upon activation ofPKC by TPA application in a time and dose-

dependent manner. This PKC dependent induced NPY mRNA is also significantly
inhibited by magnetic field exposure.

MATEmALS AND

Magnetic field(MF)exposure conditions. A cell culture incubator containing a
modified Merrit coil consisting of 3 square coils 14" in diameter separated from each

other by one-half the diameter with the number of wire turns in each coil in a 2:1:2

configuration (52:26:52) was used for MF exposures. Unless stated otherwise, all
magnetic field exposures were 1 gauss^^ (1OOuTesla) sinusoidal at a frequency of60
Hz.

Materials. A plasmid pBLNPYl containing the cDNA coding for rat brain prepro
NPY was a generous gift from Dr. Steve Sabol (National Institutes of Health,
Bethesda, Md.) Forskolin and TPA were from Sigma. Nerve Growth Factor(NGF)
was obtained from Upstate Biotechnology Inc. Forskolin and TPA were dissolved in
95% ethanol; NGF was dissolved in water. In each experiment the final concentration
of ethanol in the cell culture dishes was < 0.2%. This alcohol concentration appeared

to have no effect on cell morphology. Control dishes were also exposed to equal,
concentrations of ethanol.

Cell culture. PC-12 cells, obtained from Dr. Gordon Gurhoff through Dr. Steve Sabol

(National Institutes of Health, Bethesda Md.) were grown in DME tissue culture

medium containing 5% horse serum and 5% fetal calf serum in an incubator with a
humidified atmosphere of 5% C02/95% air with a background MF of < 0.002 gauss.
Cell culture medium was changed every two days. The cells were grown for 1 week

to 5(3-90% confluency prior to assay.

Preparation of total cellular RNA. Total cellular RNA was extracted with a
ski P and

Sacchi N., 1987), precipitated with ethanol and quantified by absorbance at 260nm
(40pg RNA/unit

Northern blot analysis. Equal amounts of RNA (25-50pg) were electrophoresed in

membranes. The membranes were dried at 80 degrees and U.V. cross linked. The

integrity ofthe RNA was determined visually by the staining of the membranes with
metbylene blue with no degradation noted. The membranes were hybridized with the

random-prime labeled (2-3 X 10^ cpm/ug)511 basepair EcoRl insert of the pBLNPYl
plasmid (Higucbi H. et. al, 1988), and a linearized plasmid containing glyceraldebyde
urs.

washed per standard protocols with a final wash of.5 X SSPE, 1% SDS for 20 min. at

42° C. and exposed to x-ray film overnight. The GPDH gene does not seem to be

regulated by the compounds used or by MF exposure (Sabol S. et. al., 1990; Liburdy
R. et. al., 1993). Films were analyzed using the JAVA (Jandel Sci.) system of

scarming densitometry. Results are expressed as Relative NPY mRNA (gray units
NPY inRNA/ gray units GPDH mRNA). Statistics were done using a Student's T-test

comparing, independently, relative NPY mRNA of sham exposed vs MF exposed.

■■

RESULTS

Stimulation of PC-12 cells with forskolin, TPA,and fdrskolin + TPA increases

levels of NPY mRNA. Previously published data (Higuchi H. eA a/., 1988) indicated
increases in NPY mRNA in PC-12 cells upon a 24 hour exposure to forskolin(20uM),

TPA (lOOnM), and forskolin(20uM)+ TPA(lOOnM) with the combination of the two
chemicals producing a synergistic increase in NPY mRNA levels. To replicate this

previous data, cells were exposed to forskolin(20uM), TPA (lOOnM), and forskolin
(20uM)+ TPA(lOOnM)for 24 hours Total RNA was extracted and analyzed for
relative NPY mRNA. Confirming the previously published results, NPY mRNA levels
were 6, 4, and 12 times those of controls, respectively after Chemical stimulation
(Figure 1).

MF exposure inhibits the cAMP/PKCdependent synergistic induction of NPY
mRNA in cells exposed for 24 hours with varying TPA concentrations. After

replicating previously published data, 2 identical experiments were performed where
cells were exposed to forskolin(20uM)+ TPA (12, 25, 50, and lOOnM)+/- MF for 24

hours A previous publication (Cain C. e/. a/., 1987) has indicated that in some cases,
magnetic field effects can only be seen upon sub-maximal stimulation of specific

signal transduction pathways. Therefore, the stimulation of the protein kinase C signal
transduction pathway was varied by varying the concentration of TPA in the presence
of maximal forskolin. The maximal cpncentration of TPA in the presence of forskolin

appears to be 50nM for the conditions employed in this laboratory. In experiment 1,
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there was a decline in NPY mRNA of those cells exposed to the MF by 51, 40, 50,

and 0% corresponding to 12, 25, 50, and lOOnM TPA in the presence of forskolin
(20uM)(Figure 2a). In the second experiment, the levels of NPY mRNA declined in

cells exposed to MF by 0, 28, 25, and 35% corresponding to 12, 25, 50, and lOOnM
TPA respectively in the presence of forskolin(20uM)(Figure 2b).
Kinetic study of forskolin plus TPA induced NPY mRNA. To determine when the
maximal forskolin(20uM)plus TPA (50nM)synergistic induction of NPY mRNA

occurs using the protocols employed by this laboratory, a kinetic stiidy was performed.

The synergistic induction of NPY mRNA begins at 2 hours(the earliest time taken)
and reaches maximum levels (51-fold) at 8 hours. NPY mRNA level then begins to
decline but never reaches basal levels by 24 hours of exposure (Figure 3). This data is
somewhat contradictory to previously published data (Higuchi H. et. al, 1988)that
shows maximum levels at 24 hours of exposure.

MF exposure inhibits the cAMP/PKC dependent synergistic induction of NPY
mRNA in cells exposed for 8 hours with varying TPA concentrations. Because

maximum levels of forskolin(20uM)plus TPA(50nM)induced NPY mRNA occurs at
8 hours after chemical stimulation, cells were exposed to forskolin(20uM)plus TPA

(12, 25, 50, and ICQ nM)plus or minus MF exposure for 8 hours. The NPY mRNA

levels in cells exposed to MF were 20, 20, 45, and 20% less than unexposed cells

corresponding to 12, 25, 50, and 1OOnM TPA + forskolin(20uM)respectively. A
second experiment with n=4 showed an average 27% decline in NPY mRNA in cells

exposed to forskolin(20uM)+ TPA (50nM)+ MF. This inhibition was statistically

significant at p < 0.01 (Figure 4).
Kinetic studies of forskolin and TPA induced NPY niRNA- In order to determine

if the decline in forskolin plus TPA induced NPY mRNA by MF exposure was the
result of MF effects on a specific signal transduction pathway, kinetic studies of both
forskolin and TPA induced NPY mRNA were performed. ■ Cells were exposed to

forskblin(TOuh^ or TPA(50nM)for 2,4,8, 12^ and 24 hours. Total RNA
extracted and analyzed for relative NPY mRNA. The forskolin induced NPY mRNA

begto at 2lhours and naaxirh^^

at 8 hours(10-foId), staying relatively constant

through 24 hours of chemical exposure. The TPA induced NPY mRNA begatn at 2
hours, niaximized at 8 hdtirs (20-fold) and began to decline by 24 hours although not
quite reaching basal levels (Figure 5).

TPA induces NPY mRNA in a time and dose dependent manner by activation of

PKC in PC-12 cells. Previous reports have shown either no change (Higuchi H. et.
al, 1988) or increases(Sabol S. et. al, 1990)in NPY mRNA upon TPA application in
PC-12 cells, with the increase only shown at 24 hours of chemical application. In this

lab, I have shown that there is a niarked increase in NPY iriR^

TPA

application. This increase is time dependent, beginning at two hours and maximizing
at 8 hours of chemical exposure, and TPA dose dependent with increases beginning at

6nM and maximizing at 50nM (Figure 6a). In an attempt tb shpw this PKC induction
of NPY mRNA could be hormonally regulated, the previously published induction of

NPY mRNA by Nerve Growth Factor(Sabol S. e/. a/., 1990; Higuchi H. et. al, 1992)
was examined for PKC dependency. Cells were exposed to TPA(2uM)for 24 hours to

10

down-regulate the available PKG. The cells were then subsequently stimulated with
either TPA(SOnM)or Nerve Growth Factor (50ng/ml) for 6 hours. Total RNA was
extracted and analyzed for relative NPY mRNA. Those cells that were exposed to the

high concentration of TPA for 24 hours were unable to respond to subsequent TPA
stimulation, but were able to respond to the NGF producing NPY mRNA levels

comparable to those previously described (Sabol S. et. at, 1990; Higuchi H. et. al,
1992)(Figure 6b). Therefore, the production of NPY mRNA by exposure to TPA and
NGF occur by two distinct mechanisms.
MF exposure inhibits, speeifieally, PKC dependent induction of NPY mRNA in

FC-12 cells. To determine if a specific signal transduction pathway was affected by
magnetic field exposure, PC-12 cells were exposed to TPA (50nM)and forskolin
(20uM), plus or minus MF for 8 hours. There was a statistically significant decline in
the production of NPY mRNA in cells exposed to TPA(SOnM)and the magnetic field
compared to sham exposed (n = 4; p <.05).

No changes were seen in the control(no

chemical) or forskolin induced conditions (Figure 7).
Determination of half-life of cAMP,PKC,and cAMP + PKC induced NPY

mRNA. Previous reports have indicated the half-life of the forskolin/TPA induced
NPY mRNA in fetal brain cells to be at least 12 hours(Magni P. et. al, 1992). The

goal was to determine the half-life of the induced NPY mRNA in PC-12 cells. Cells
were exposed to forskolin(20uM), TPA (SOnM), and forskolin(20uM)+ TPA

(SOnM),for 6 hours. After the six hour stimulation, DRB (S,6-dichloro-l-B-D
ribofuranosyl-benzimidazole)(6SuM), an inhibitor of transcription(Tamm L, and
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Kikuchi T., 1979), was added. TotalRNA was isolated before, and 6, 11, 24, and 30
hours after the addition of DBR. The half-life was determined to be approximately 12

hours for all conditions (Figure 8).

MF exposure does not affect the half-life of TPA induced NPY mRNA. To
determine if the half-life lability was affected by exposure to magnetic fields, cells

were exposed to TPA(5OnM)plus or minus MF exposure for 8 hours at which time
DRB(65uM) was added to stop transcription. RNA was extracted before, and 8, 14,

20, and 32 hours after the addition of DRB. Those cells exposed to TPA and
magnetic field produced 35%(p < 0.02) less NPY mRNA than did sham exposed cells
in the first eight hours. The half-life was determined to be 12 hours. The half-life was
not affected by exposure to magnetic fields (Figure 9).
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Fig. 1. Stimulation of PC-12 ceils with forskolin, TPA,and forskolin + TPA
increases levels of NPY mRNA. PC-12 cells(80% confluent at time of chemical

stimulation) were stimulated for 24 hours with F-forskolin(20uM), T-TPA (lOOnM),
and FT-forskolin(20uM)+ TPA(lOOnM)Or C-control. Relative NPY mRNA is

expressed as the ratio of gray units NPY mRNA/ gray imits GPDH with the control
ratio equal to 1.
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16

12

Q1

E
10

>■
CL

a •
<D
>

6 •
4 

0

a:

0

T

FT

C- control; F-for»kolln (20uM); T-TPA (lOOnM)

rr-for«tcolln (20uM) + TPA (lOOnM); all for 2+ houra.

Stimuiatlon of PC-1 2 cells with forskolm,
TPA, and forskoiin + TPA increases leveis
of NPY mRNA

14

Fig 2. MF exposure inhibits cAMP/PKC dependent synergistic induction of NPY
mRNA in cells exposed for 24 hours with varying TPA concentrations. A)PC-12

cells(70-90% confluent) were exposed to forskolin(20uM), forskolin(20uM)+ TPA
(12nM), forskolin(20uM)+ TPA (25nM), forskolin(20uM)+ TPA (50nM), and
forskolin(20uM)+ TPA (lOOnM) with or without 1 G,60 Hz magnetic field for 24

hours. Symbols: o-sham exposed;•-MF exposed. Relative NPY mRNA is expressed
as the ratio of gray units NPY mRNA/ gray units GPDH with the control ratio equal
to 1. B)A replicate study with the same conditions as A.
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Figure 2
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Fig. 3. Kinetic study of forskolin + TPA induced NPY mRNA. A)PC-12 cells
(70-90% confluent) were exposed to forskolin (20uM)-i- TPA(50nM)for 2, 4, 8, and
24 hours. Relative NPY mRNA is expressed as the ratio of gray units NPY mRNA/

gray imits GPDH with the control ratio equal to 1.
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Figure 3
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Fig. 4. MF exposure inhibits the cAMP/PKC dependent synergistic induction of

NPY mRNA in cells exposed for 8 hours with varying TPA concentrations. PC
12 cells(70-90% confluent) were exposed to forskolin(20uM), forskolin(20uM)+

TPA (12nM), forskolin(20uM)+ TPA (25nM), forskolin(20uM)+ TPA (50nM), and

forskolin(20uM)+ TPA (lOOnM)for 8 hours with and without 1 G,60 Hz magnetic
field exposure. Symbols: O -sham exposed; •-MF exposed. B)PC-12 cells(70-90%
confluent) were exposed to forskolin(20uM)+ TPA (50nM)for 8 hours with and

without magnetic field exposure (n=4/condition). Symbols: o-sham exposed; •-MF
exposed.

19

Figure 4
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Fig. 5. Kinetic studies of forskolin and TPA induced NPY niRNA. A)PC-12 cells
(70-90% confluent) were exposed to forskolin(20uM)for 2, 4,6, 8, and 24 hours. B)
PC-12 cells(70-90% confluent) were exposed to TPA(50nM)for 2, 4, 8, and 24
hours. Relative NPY mRNA is expressed as the ratio of gray units NPY mRNA/ gray
units GPDH with the control ratio equal to 1.
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Fig. 6. TPA induces NPY mRNA in a time and dose dependent manner by
activation of PKC in PC42 cells. A)PG-12 cells(70-90% confluent) were exposed

to TPA (6, 12, 25, 50, 100, and 2()0nMyfor 6 hours. B)PC-12 cells were exposed to
TPA(2uM)for 24 hours with subsequent exposure to TPA(50nM)for 6 hours(Tt),
TPA(2uM)for 24 hours with subsequent exposure to Nerve Growth Factor (50ng/ml)
for 6 hours(TN), TPA(50nM)for 6 hours (t). Nerve Growth Factor (5Ong/ml)for 6

hours(N), and controls with no chemical exposure (C). Relative NPY mRNA is

expressed as the ratio of gray units NPY mRNA/ gray units GPDH with the control
ratio equal to 1.
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Fig. 7. MF exposure inhibits, specifically, PKC dependentinduction of NPY

mRNA in PC-12 cells. PC-12 ceils(70-90% confluent) were exposed to forskolin
(20uM), and TPA(50nM) with without 1 G,60 Hz magnetic field for eight hours

(n=4/condition). Relative NPY mRNA is expressed as the ratio of gray units NPY
mRNA/ gray units GPDH with the control ratio equal to 1. Symbols:i—'-sham
exposed;

-MF exposed.
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Fig. 8. Determination of half-life of cAMP,PKC,and cAMP + PKC induced
mRNA. PC-12 ceils(70-90% confluent) were exposed to forskolin (20uM), TPA

(50nM), and forskolin(20uM)+ TPA(50nM), or control(unexposed)for 6 hours at
which time DRB(65uM)(a transcriptional inhibitor) was added. RNA was extracted
and analyzed at the indicated timepoints for NPY mRNA. NPY mRNA is expressed

in grey imits. Symbols:O "forskolin (20uM); □ -TPA (50nM); O -forskolin (20uM)
+ TPA (50nM); V -control.
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Fig. 9.

PC-12 cells(tO-90% confluent)

to TPA(50nM) with or without 1 G,60

Hz magnetic field for 6 hours at which time DRB(65uM)was added. Tdtal RNA was

extracted and ana:lyzed for NPY mRNA at the timepoints indicated. NPY mRHA is
expressed in grey units. Symbols: o -sham exposed; •-MF exposed.
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DISCUSSION

In this stud^j previdus reports of chemically induced

PC-12 cells

vvere replicated. Alsp, it was demonstrated that NPY rnRNA is regulated in PC-12
cells by PKC in a time and dose dependent manner. This PKC dependent induction of
NPY niRNA appears to be physiologically relevant as exposure to ITA causes

significant increases in NPY secretion from fetal rat brain cells(Magni P. et. ai, 1992)
and increases in NPY mRNA in 5-6 day old rat brain primary cell cultures

(unpublished data). 1 conclude that from the above data, the forskolin + TPA and
TPA induced production of NPY mRNA are significantly inhibited in PC-12 cells

exposed to a 1 gauss, 60 Hz magnetic field for 8, and 24 hours. It must be noted that
not in all cases was there a decline in chemically induced NPY mRNA in MF exposed
cells. In the case of the forskolin + TPA induced NPY mRNA, 11 of 15 experiments

(75%), showed declines from 20% - 50%, while 3 showed no changes, and one
showed an increase of 50%. In the case of the TPA induced NPY mRNA,5 of 8

experiments(63%)showed declines from 20% - 40%, while the others showed no

changes. In every case, when both forskolin + TPA and TPA conditions were

employed in the same experiment, when there was no change in induced NPY mRNA
upon magnetic field exposure for one condition, there was no change for the other.
This could suggest that the state of the cell population, for example, growth rate,
confluence, etc... at time of exposure may be extremely important for this observed

effect of magnetic field exposure. Some variation in the magnitudes of NPY mRNA
induction exists between similar experiments. 1 attribute these variations to possible
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differences in cell populations, freshness of reagents, and differences in basal levels of
NPY mRNA at the time of assay.
This data indicate that the observed decline in forskolin + TPA induced NPY

mRNA in MF exposed cells is likely due to the effects on the phoshoinositide/PKC

dependent signal transduction pathway as indicated by the decline of NPY mRNA in
cells exposed to only TPA and MF. It has been shown that the stabilization of other
transcripts in PC-12 cells can be increased by the activation ofPKC (PerroneBizzozero N. et. al, 1993). According to our data, PKC activation does not lead to

stabilization of the NPY mRNA. There is no change in chemically induced NPY
mRNA half-life upon exposure to magnetic fields. I can only conclude that the
observed decline in PKC induced NPY mRNA upon exposure to magnetic fields is not

at the posttranscriptional level. The effect is perhaps at a PKC dependent event
occurring at the level of transcription.
Because of the many physiological roles of NPY,changes in circulating blood
and brain levels could have significant clinical implications. Do relationships exist

between changes in NPY or changes in the mechanisms of NPY production and

reported biological effects associated with exposure to magnetic fields? There exists a

are in

part regulated by NPY. For instance, there have been reports of changes in blood

pressure(Cook M. et. al, 1992), intracellular calcium levels(Wallcczek J. et. al,
1990; Liburdy R. et. al, 1993), catecholamine secretion (Dixey R. and Rein G., 1982)
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and production and secretion of the pineal hormone, melatonin in subjects exposed to
magnetic fields (Reiter R. et. al, 1992; Wilson B. et. al. 1981, 1986, 1990; Welker H.
et. al, 1983). All of these phenomena appear to be regulated by NPY (Lundherg J. et.
al, 1982; Olcese J. et. al, 1991; Vacas M. el al, 1987; Reuss S. el al, 1989;

Erdbrugger W. et. al, 1993; Motulsky H. and Michel M., 1988; Michel M. el al,
1990; Guy J. and Pelletier G., 1988). It is possible that exposure to magnetic fields
affects the natural brain and body production of NPY which could lead to the before

mentioned physiological changes associated with magnetic field exposure. Alterations

in PKC dependent signal transduction mechanism by MF exposure may also help to

explain previously published MF effects. In PC-12 cells, tyrosine hydroxylase, the
rate-determining enzyme involved in the production of norepinephrine, appears to he
regulated by events involving protein kinase C(Vyas S. et. al, 1990). Norepinephrine
appears to be the primary regulator of melatonin production(Moore R. el al, 1968,
Reiter R., 1992). Neurotransmitter release from sympathetic neurons appears to be

regulated by PKC (Heinrich J. el al, 1987).
The question still remains, "Is there a relationship between NPY and cancer?"

There is one plausible connection to exposure to EMF's, changes in NPY levels, and
cancer. This connection can be hypothesized two different ways. First, it has been

demonstrated that pineal melatonin concentrations are lowered upon exposure to EMF.
Melatonin has been shown to play a role in some cancers associated with EMF

exposure. In patients with either prostate or breast cancer, blood levels of melatonin
are 40%-70% below normal (Bartsch C. el al, 1985, 1989). This decline is
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specifically due to a decline iii brain secretion which is also the case with exposure to
EMF. It is currently Unknown why melatonin levels are suppressed in the presence of

EMFi although this dissertation could shed some light. Neuropeptide Y appears to be

a positive regulator of melatonin production by the pineal gland. This dissertation has
shown specific dieclines in the production ofNPY mRN^in PG-12 cells exposed to

EMF. The connection to pineal cells is only speculative, but plausible. The second
hypothesis involves the levels of NPY itself. In children diagnosed with acute
leukemia, a cancer associated with EMF exposure, blood levels of NPY were

significantly higher than those without the cancer. Of the children tested, those with

highest levels of NPY had a significantly better survival rate than those with lower
levels(Kogner P. e/. a/., 1992). NPY immunoreactivity was detected in tumors of

children with neuroblastoma; Again, those with the highest immunoreactivity showed
better survival rates.(Cohen P. et. al, 1990) These data suggest that NPY may itself

play a role in the immune response to certain forms of cancer. It has been suggested
that the presence of NPY be used as a marker to determine between benign and
malignant pheochromocytoma tumors. In that study, NPY was present in all (9 of 9)

benign tumors, but in only 4 of 11 malignant tumors(Helman L. et. al, 1989).
For this inliibition of induced NPY mRNA by MF exposure to have any real

significance, the resultant NPY levels must also change. Because NPY can be stored
in vesicles and secreted upon command,this effect of MF exposure could be

happening earlier than what is shown here. If chemical application to the cells causes
immediate release of the stored protein, the results I have shown could be due to

34

changes in possible feedback mechanisms. For instance, if the MF exposure causes a

suppression in the immediate chemically induced neuropeptide secretion, this might
show up in declined levels of production to replace the stored NPY. Also, does this
decline in NPY production upon MF exposure result in a decline of stored peptide
which in turn would cause a decline in subsequent release? Is there a natural hormone

in the body that is capable of inducing cAMP and PKC in similar chromaffin cells
within the body, and does this stimulation lead to changes in circulating NPY levels?

NPY mRNA that is affected by MF exposure needs to be determined, as well. This

perhaps by inhibiting the effects of TPA on cytoplasmic PKC. Is there an inhibition
of the phosphorylations by PKC upon MF exposure? Many more experiments need to

be performed to identify the exact mechanism in this system that is affected by MF
exposure.

NPY may play a role in cancer defense by regulating the secretion of brain
melatonin and by its own presence in the blood and tissues. If the decline in protein
kinase C induced NPY mRNA upon magnetic field exposure occurs in the living

system and, if this decline leads to a subsequent decline in brain and blood levels of
the neuropeptide, the findings we have just reported could lead to physiological

explanations of some magnetic field induced phenomena.
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